PROMIS NEUROSCIENCES INC. Adjustments to Additional Paid in Capital, Warrant Issued
PROMIS NEUROSCIENCES INC. (PMN) reported Adjustments to Additional Paid in Capital, Warrant Issued of $697.66 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-25
- PROMIS NEUROSCIENCES INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-12-31 was $0.00.
- PROMIS NEUROSCIENCES INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $697.66K.
- PROMIS NEUROSCIENCES INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-12-31 was $0.00.
- PROMIS NEUROSCIENCES INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-09-30 was $1.29M.
- PROMIS NEUROSCIENCES INC. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $697.66K, a 91.97% decline from fiscal 2024.
- PROMIS NEUROSCIENCES INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $8.69M, a 574.94% increase from fiscal 2023.
- PROMIS NEUROSCIENCES INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $1.29M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $697.66K derived: sum of 2 quarters · filed 2026-03-25 | $697.66K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $697.66K 10-Q · filed 2025-11-12 | $697.66K 10-Q · filed 2025-11-12 | ||
| 2024-12-31 | $8.69M 10-K · filed 2026-03-25 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.29M derived: sum of 2 quarters · filed 2025-03-31 | $1.29M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.29M 10-Q · filed 2024-11-14 | $1.29M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |